M. Sabat

994 total citations
32 papers, 621 citations indexed

About

M. Sabat is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, M. Sabat has authored 32 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 11 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in M. Sabat's work include Synthesis and biological activity (13 papers), Cytokine Signaling Pathways and Interactions (9 papers) and Quinazolinone synthesis and applications (5 papers). M. Sabat is often cited by papers focused on Synthesis and biological activity (13 papers), Cytokine Signaling Pathways and Interactions (9 papers) and Quinazolinone synthesis and applications (5 papers). M. Sabat collaborates with scholars based in United States, Spain and Japan. M. Sabat's co-authors include Carl R. Johnson, Biswanath De, Adam Gołȩbiowski, Todd A. Brugel, Matthew J. Laufersweiler, John C. VanRens, Lily C. Hsieh, Michael J. Janusz, Michael P. Clark and Roger G. Bookland and has published in prestigious journals such as Immunity, Journal of Medicinal Chemistry and Nature Structural & Molecular Biology.

In The Last Decade

M. Sabat

31 papers receiving 596 citations

Peers

Countries citing papers authored by M. Sabat

Since Specialization

Citations

This map shows the geographic impact of M. Sabat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Sabat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Sabat more than expected).

Fields of papers citing papers by M. Sabat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Sabat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Sabat. The network helps show where M. Sabat may publish in the future.

Co-authorship network of co-authors of M. Sabat

This figure shows the co-authorship network connecting the top 25 collaborators of M. Sabat. A scholar is included among the top collaborators of M. Sabat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Sabat. M. Sabat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tuft cell-derived acetylcholine promotes epithelial chloride secretion and intestinal helminth clearance 2024 ·Immunity ·(unknown), Connie Fung, (unknown), (unknown), (unknown), Zuojia Chen, Margaret M. McDaniel, Darshan N. Kasal, John W. McGinty, Kaitlyn A. Barrow, Lucille M. Rich, (unknown), M. Sabat, Jason S. Debley, Chuan Wu, Richard A. Myers, Michael R. Howitt, Jakob von Moltke	28
2	Identification of positive modulators of TRPM5 channel from a high-throughput screen using a fluorescent membrane potential assay 2022 ·SLAS DISCOVERY ·Caterina Virginio, Laura Aldegheri, (unknown), Daniela Brodbeck, Laurent Brault, Luca F. Raveglia, (unknown), M. Sabat, Richard A. Myers	6
3	The discovery of (1R, 3R)-1-(3-chloro-5-fluorophenyl)-3-(hydroxymethyl)-1,2,3,4-tetrahydroisoquinoline-6-carbonitrile, a potent and selective agonist of human transient receptor potential cation channel subfamily m member 5 (TRPM5) and evaluation of as a potential gastrointestinal prokinetic agent 2022 ·Bioorganic & Medicinal Chemistry ·M. Sabat, Luca F. Raveglia, Laura Aldegheri, (unknown), Federica Bianchi, Laurent Brault, Daniela Brodbeck, Aldo Feriani, (unknown), (unknown), R. A. Myers, Laura Piccoli, (unknown), John Tyhonas, (unknown), (unknown), Caterina Virginio	2
4	Structures of the TRPM5 channel elucidate mechanisms of activation and inhibition 2021 ·Nature Structural & Molecular Biology ·Zheng Ruan, (unknown), Ian J. Orozco, M. Sabat, Richard A. Myers, (unknown), Juan Du, Wei Lü	44
5	Biochemical and Cellular Profile of NIK Inhibitors with Long Residence Times 2020 ·SLAS DISCOVERY ·(unknown), Charles E. Grimshaw, (unknown), (unknown), Chris Proffitt, (unknown), Ron de Jong, M. Sabat, (unknown), Jacques Ermolieff	0
6	Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators 2017 ·Bioorganic & Medicinal Chemistry Letters ·Zacharia S. Cheruvallath, Stephen L. Gwaltney, M. Sabat, (unknown), Haixia Wang, Andy Jennings, David J. Hosfield, Bumsup Lee, Yiqin Wu, (unknown), Charles E. Grimshaw	15
7	Design, synthesis and optimization of 7-substituted-pyrazolo[4,3-b]pyridine ALK5 (activin receptor-like kinase 5) inhibitors 2017 ·Bioorganic & Medicinal Chemistry Letters ·M. Sabat, Haixia Wang, (unknown), J. David Lawson, (unknown), Ruhi Kamran, Mark S. Hixon, Douglas R. Dougan	18
8	Design, synthesis and optimization of novel Alk5 (activin-like kinase 5) inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Haixia Wang, J. David Lawson, (unknown), Ruhi Kamran, Mark S. Hixon, (unknown), Douglas R. Dougan, M. Sabat	10
9	Fragment-Based Discovery of a Small Molecule Inhibitor of Bruton’s Tyrosine Kinase 2015 ·Journal of Medicinal Chemistry ·Christopher R. Smith, Douglas R. Dougan, (unknown), Toufike Kanouni, (unknown), J. David Lawson, M. Sabat, Ewan R. Taylor, (unknown), (unknown)	55
10	Design, synthesis and SAR of novel glucokinase activators 2013 ·Bioorganic & Medicinal Chemistry Letters ·Zacharia S. Cheruvallath, Stephen L. Gwaltney, M. Sabat, (unknown), Jun Feng, Haixia Wang, (unknown), (unknown), Andy Jennings, David J. Hosfield, Bumsup Lee, Yiqin Wu	27
11	Development of N-4,6-pyrimidine-N-alkyl-N′-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jennifer A. Maier, Todd A. Brugel, M. Sabat, Adam Gołȩbiowski, Matthew J. Laufersweiler, John C. VanRens, Corey R. Hopkins, Biswanath De, Lily C. Hsieh, Kimberly K. Brown, (unknown), Michael J. Janusz	12
12	The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck) 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Sabat, John C. VanRens, Matthew J. Laufersweiler, Todd A. Brugel, Jennifer Maier, Adam Gołȩbiowski, Biswanath De, (unknown), Lily C. Hsieh, Richard L. Walter, Marlene Mekel, A.G. Evdokimov, Michael J. Janusz	57
13	The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-α production 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Sabat, John C. VanRens, Michael P. Clark, Todd A. Brugel, Jennifer Maier, Roger G. Bookland, Matthew J. Laufersweiler, (unknown), Adam Gołȩbiowski, Biswanath De, Lily C. Hsieh, Richard L. Walter, Marlene Mekel, Michael J. Janusz	11
14	Development of N-2,4-pyrimidine-N-phenyl-N′-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 1 2006 ·Bioorganic & Medicinal Chemistry Letters ·Todd A. Brugel, Jennifer A. Maier, Michael P. Clark, M. Sabat, Adam Gołȩbiowski, Roger G. Bookland, Matthew J. Laufersweiler, (unknown), John C. VanRens, Biswanath De, Lily C. Hsieh, Marlene Mekel, Michael J. Janusz	15
15	Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3) 2006 ·Bioorganic & Medicinal Chemistry Letters ·Michael P. Clark, Kelly M. George, Roger G. Bookland, Jack Chen, (unknown), Kumar Thakur, Wenlin Lee, (unknown), (unknown), Todd A. Brugel, John C. VanRens, Matthew J. Laufersweiler, Jennifer A. Maier, M. Sabat, Adam Gołȩbiowski, (unknown), (unknown), Biswanath De, George Zhang	50
16	The development of novel 1,2-dihydro-pyrimido[4,5-c]pyridazine based inhibitors of lymphocyte specific kinase (Lck) 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Sabat, John C. VanRens, Todd A. Brugel, Jennifer Maier, Matthew J. Laufersweiler, Adam Gołȩbiowski, Biswanath De, (unknown), Lily C. Hsieh, (unknown), (unknown), Eric G. Suchanek, Michael J. Janusz	18
17	Development of N-2,4-pyrimidine-N-phenyl-N′-alkyl ureas as orally active inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 2 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jennifer A. Maier, Todd A. Brugel, Michael P. Clark, M. Sabat, Adam Gołȩbiowski, Roger G. Bookland, Matthew J. Laufersweiler, (unknown), John C. VanRens, Biswanath De, Lily C. Hsieh, Kimberly K. Brown, (unknown), Richard L. Walter, Michael J. Janusz	7
18	The development of novel inhibitors of tumor necrosis factor-α (TNF-α) production based on substituted [5,5]-bicyclic pyrazolones 2004 ·Bioorganic & Medicinal Chemistry Letters ·Matthew J. Laufersweiler, Todd A. Brugel, Michael P. Clark, Adam Gołȩbiowski, Roger G. Bookland, (unknown), M. Sabat, (unknown), John C. VanRens, Biswanath De, Lily C. Hsieh, S.A. Heitmeyer, (unknown), Kimberly K. Brown, Marlene Mekel, Richard L. Walter, Michael J. Janusz	17
19	The development of new bicyclic pyrazole-based cytokine synthesis inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Adam Gołȩbiowski, Michael P. Clark, Matthew J. Laufersweiler, Todd A. Brugel, M. Sabat, Roger G. Bookland, (unknown), John C. VanRens, Biswanath De, Lily C. Hsieh, (unknown), Michael J. Janusz, Richard L. Walter	17
20	Synthesis of (2 R ,4 R )- and (2 S ,4 S )-4-hydroxypipecolic acid derivatives and (2 S ,4 S )-(−)-SS20846A 2001 ·Tetrahedron Letters ·M. Sabat, Carl R. Johnson	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact